Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus.

Junzhang Huang, Bing Chen
Author Information
  1. Junzhang Huang: Department of Neurosurgery, Guangdong Medical University, Zhanjiang City, Guangdong Province, China. ORCID
  2. Bing Chen: Department of Neurosurgery, Guangdong Medical University, Zhanjiang City, Guangdong Province, China.

Abstract

Objectives: To investigate the value of cerebrospinal fluid chloride (CSF-Cl), cerebrospinal fluid glucose (CSF-GS), cerebrospinal fluid microalbumin (CSF-MALB), and cerebrospinal fluid adenosine deaminase (CSF-ADA) in the differential diagnosis of secondary hydrocephalus.
Methods: 103 patients with secondary hydrocephalus treated in our hospital from January 2018 to April 2022 were selected. According to different types, it is divided into the hemorrhagic hydrocephalus group and tumor hydrocephalus group. By detecting the levels of inflammatory factors such as CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in the two groups, we can analyze the value of these inflammatory factors in the differential diagnosis of secondary hydrocephalus.
Results: The level of CSF-MALB in the hemorrhagic hydrocephalus group was significantly higher than that in the tumor hydrocephalus group, and the difference between the two groups was statistically significant ( < 0.05). There was no significant difference in the levels of CSF-Cl, CSF-GS, and CSF-ADA between the two groups ( > 0.05). The area under ROC curve (AUC) of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in the differential diagnosis of secondary hydrocephalus was 0.438, 0.553, 0.750, and 0.542, respectively, sensitivity was 15.1%, 45.3%, 79.2%, and 18.9%, respectively, and specificity was 96.0%, 80.0%, 80.0%, and 94.0%, respectively.
Conclusions: The inflammatory reaction of hemorrhagic hydrocephalus was significantly greater than that of tumor hydrocephalus. Moreover, CSF-MALB is closely related to the pathogenesis of hemorrhagic hydrocephalus. At the same time, CSF-MALB can be used as a good index for rapid differential diagnosis of secondary hydrocephalus.

References

  1. World Neurosurg. 2022 Jan;157:e286-e293 [PMID: 34648991]
  2. Metabolites. 2022 Jan 14;12(1): [PMID: 35050201]
  3. J Neurosurg Pediatr. 2022 Jan 21;29(4):435-443 [PMID: 35061994]
  4. J Neurosurg Pediatr. 2022 Jan 28;29(4):444-453 [PMID: 35090135]
  5. Br J Neurosurg. 2022 Jan 10;:1-4 [PMID: 35001779]
  6. Arch Soc Esp Oftalmol (Engl Ed). 2022 Jan;97(1):40-43 [PMID: 35027144]
  7. Medicina (Kaunas). 2022 Feb 13;58(2): [PMID: 35208604]
  8. Pediatr Neurosurg. 2022;57(2):141-143 [PMID: 35026762]
  9. Anticancer Res. 2022 Mar;42(3):1189-1198 [PMID: 35220208]
  10. J Neurol Surg A Cent Eur Neurosurg. 2023 May;84(3):255-260 [PMID: 35100632]
  11. Neurosurg Rev. 2022 Feb;45(1):683-699 [PMID: 34195892]
  12. Neurosurg Rev. 2022 Feb;45(1):479-490 [PMID: 33905002]
  13. Turk Neurosurg. 2022;32(2):309-314 [PMID: 35023137]
  14. Childs Nerv Syst. 2022 Jan;38(1):115-121 [PMID: 34757453]
  15. IDCases. 2022 Jan 03;27:e01374 [PMID: 35079572]
  16. Int J Neurosci. 2023 Jul;133(7):797-805 [PMID: 34643151]
  17. J Child Neurol. 2022 Jan;37(1):80-88 [PMID: 34817276]
  18. Surg Neurol Int. 2022 Jan 05;13:6 [PMID: 35127206]
  19. Int J Environ Res Public Health. 2022 Feb 09;19(4): [PMID: 35206112]
  20. Arq Bras Oftalmol. 2023 Jan-Feb;86(1):68-70 [PMID: 35170650]
  21. World Neurosurg. 2022 Mar;159:144-145 [PMID: 34999264]
  22. Neuropediatrics. 2022 Feb;53(1):1-6 [PMID: 34255331]
  23. Childs Nerv Syst. 2022 Feb;38(2):239-252 [PMID: 35022855]
  24. Br J Neurosurg. 2022 Jan 11;:1-5 [PMID: 35015601]
  25. AJNR Am J Neuroradiol. 2022 Feb;43(2):223-229 [PMID: 34969666]
  26. World Neurosurg. 2022 May;161:e339-e346 [PMID: 35134579]
  27. Eur J Neurol. 2022 Mar;29(3):942-946 [PMID: 35141991]
  28. Trop Biomed. 2016 Mar 1;33(1):102-108 [PMID: 33579147]

MeSH Term

Chlorides
Diagnosis, Differential
Glucose
Humans
Hydrocephalus
Tuberculosis, Meningeal

Chemicals

Chlorides
Glucose

Word Cloud

Created with Highcharts 10.0.0hydrocephalusCSF-MALB0CSF-ClCSF-GSCSF-ADAsecondarycerebrospinalfluiddifferentialdiagnosishemorrhagicgroup0%tumorinflammatorytwogroupsrespectivelyvaluelevelsfactorscansignificantlydifferencesignificant0580Objectives:investigatechlorideglucosemicroalbuminadenosinedeaminaseMethods:103patientstreatedhospitalJanuary2018April2022selectedAccordingdifferenttypesdivideddetectinganalyzeResults:levelhigherstatistically<>areaROCcurveAUC438553750542sensitivity151%453%792%189%specificity9694Conclusions:reactiongreaterMoreovercloselyrelatedpathogenesistimeusedgoodindexrapidValueDifferentialDiagnosisSecondaryHydrocephalus

Similar Articles

Cited By